Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers

Inclusion Criteria: * Women of childbearing potential (WOCBP) must have a negative pregnancy test * Parkinson's disease (PD) patients must be at least 40 years old * Healthy volunteers must be at least 30 years old * PD patients must have a PD diagnosis, according to the 2015 Movement Disorder Society criteria, with bradykinesia, and at least one of the following: muscular rigidity, or resting tremor with no other suspected cause of Parkinsonism * The LRRK2 G2019S symptomatic carrier PD patients must have a documented G2019S mutation on the leucine-rich repeat kinase 2 gene (LRRK2) Exclusion Criteria: * Pregnant or lactating women * Have participated in an investigational drug trial within 30 days * Are SARS-CoV-2, COVID-19, positive within 15 days prior to blood sample collection * Have another active disease that the investigator believes could interfere with study results